Amicus Therapeutics
FOLD
#3324
Rank
โ‚น410.81 B
Marketcap
โ‚น1,310
Share price
0.14%
Change (1 day)
57.93%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2025 (TTM): โ‚น0.53 Billion

According to Amicus Therapeutics 's latest financial reports the company's current earnings are โ‚น0.59 Billion. In 2024 the company made an earning of -โ‚น2.64 Billion, an increase over its 2023 earnings that were of -โ‚น13.76 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น0.53 B-120.46%
2024 -โ‚น2.64 Billion-80.84%
2023 -โ‚น13.76 Billion-37.98%
2022 -โ‚น22.19 Billion0.2%
2021 -โ‚น22.14 Billion-11.92%
2020 -โ‚น25.14 Billion-22.94%
2019 -โ‚น32.62 Billion1.95%
2018 -โ‚น32 Billion-22.27%
2017 -โ‚น41.16 Billion120.39%
2016 -โ‚น18.68 Billion54.24%
2015 -โ‚น12.11 Billion88.63%
2014 -โ‚น6.42 Billion10.92%
2013 -โ‚น5.79 Billion21.36%
2012 -โ‚น4.77 Billion8.3%
2011 -โ‚น4.41 Billion-14.33%
2010 -โ‚น5.14 Billion753.76%
2009 -โ‚น0.61 Billion-83.31%
2008 -โ‚น3.61 Billion-4.4%
2007 -โ‚น3.78 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚น1.910 T 418,322.32%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
โ‚น174.48 B 38,117.58%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น854.35 B 187,031.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-โ‚น6.29 Billion-1,476.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.52 Billion-650.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น62.24 B 13,534.52%๐Ÿ‡บ๐Ÿ‡ธ USA